The Potential of MicroRNAs as Prostate Cancer Biomarkers.
Research output: Contribution to journal › Review article
Short noncoding RNAs known as microRNAs (miRNAs) control protein expression through the degradation of RNA or the inhibition of protein translation. The miRNAs influence a wide range of biologic processes and are often deregulated in cancer. This family of small RNAs constitutes potentially valuable markers for the diagnosis, prognosis, and therapeutic choices in prostate cancer (PCa) patients, as well as potential drugs (miRNA mimics) or drug targets (anti-miRNAs) in PCa management.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Early online date||2016 Jan 21|
|Publication status||Published - 2016|